Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Merck Solidifies RCC Position, While Bristol Gets Good SubQ Readout
Jan 29 2024
•
By
Joseph Haas
Merck demonstrates an overall survival benefit with Keytruda in RCC
More from Strategy
More from Business